Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.

Auteurs

Pradeep C-, Zeisel A, Köstler WJ, Lauriola M, Jacob-Hirsch J, Haibe-Kains B, Amariglio N, Ben-Chetrit N, Emde A, Solomonov I, Neufeld G, Piccart M, Sagi I, Sotiriou C, Rechavi G, Domany E, Desmedt C, Yarden Y

  • Date de publication

    February 2024

  • Type

    Correction, Addition

  • Review

    Oncogene

  • Researcher's name

    PICCART MARTINE

  • Hôpital

    Institut Jules Bordet

  • Service

    Médecine Oncologique

  • PMID

    38418546

  • DOI

    10.1038/s41388-024-02990-w